Rates Pressure Life Sciences
Rising Treasury yields are pressuring rate-sensitive healthcare equipment stocks like DHR as capital costs rise and investors rotate defensive.
Previous verdicts for DHR
- AI Search: RBC Price Target Lift Gives Danaher a Steady, Orderly Advance — 2026-10-05
- DHR Slides on CEO News — 2026-10-01
- DHR climbs moderately, calm — 2026-09-21
- Life Sciences Lag Rates Pressure — 2026-09-01
- Defensive Bid Extends — 2026-08-19
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works